TIANXIN PHARMA released its first-quarter performance, with a net profit attributable to the parent company of 219 million yuan, a year-on-year increase of 48.13%
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, TIANXIN PHARMA disclosed its first-quarter report for 2025, showing that the company achieved revenue of 619 million yuan, a year-on-year increase of 25.16%; net profit attributable to the parent company was 219 million yuan, a year-on-year increase of 48.13%; and net profit excluding non-recurring gains and losses was 209 million yuan, a year-on-year increase of 53.30%. The basic earnings per share were 0.50 yuan
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments